Cargando…
β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression
Endocrine therapies have been successfully used for breast cancer patients with estrogen receptor α (ERα) positive tumors, but ∼40% of patients relapse due to endocrine resistance. β-glucans are components of plant cell walls that have immunomodulatory and anticancer activity. The objective of this...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977804/ https://www.ncbi.nlm.nih.gov/pubmed/24534923 http://dx.doi.org/10.3892/ijo.2014.2294 |